Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM On Twitter
  • JABFM On YouTube
  • JABFM On Facebook
Research ArticleOriginal Research

Differences in Hypertension Medication Prescribing for Black Americans and Their Association with Hypertension Outcomes

Hunter K. Holt, Ginny Gildengorin, Leah Karliner, Valy Fontil, Rajiv Pramanik and Michael B. Potter
The Journal of the American Board of Family Medicine January 2022, 35 (1) 26-34; DOI: https://doi.org/10.3122/jabfm.2022.01.210276
Hunter K. Holt
the Department of Family and Community Medicine at the University of Illinois at Chicago (HKH); Department of Family and Community Medicine, University of California San Francisco (MBP); Division of General Internal Medicine, Department of Medicine, University of California San Francisco (GG, LK, VF); Multiethnic Health Equity Research Center, University of California San Francisco (LK, VF); UCSF Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital, San Francisco, CA (VF); Contra Costa Health Services, San Francisco, CA (RP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ginny Gildengorin
the Department of Family and Community Medicine at the University of Illinois at Chicago (HKH); Department of Family and Community Medicine, University of California San Francisco (MBP); Division of General Internal Medicine, Department of Medicine, University of California San Francisco (GG, LK, VF); Multiethnic Health Equity Research Center, University of California San Francisco (LK, VF); UCSF Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital, San Francisco, CA (VF); Contra Costa Health Services, San Francisco, CA (RP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leah Karliner
the Department of Family and Community Medicine at the University of Illinois at Chicago (HKH); Department of Family and Community Medicine, University of California San Francisco (MBP); Division of General Internal Medicine, Department of Medicine, University of California San Francisco (GG, LK, VF); Multiethnic Health Equity Research Center, University of California San Francisco (LK, VF); UCSF Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital, San Francisco, CA (VF); Contra Costa Health Services, San Francisco, CA (RP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valy Fontil
the Department of Family and Community Medicine at the University of Illinois at Chicago (HKH); Department of Family and Community Medicine, University of California San Francisco (MBP); Division of General Internal Medicine, Department of Medicine, University of California San Francisco (GG, LK, VF); Multiethnic Health Equity Research Center, University of California San Francisco (LK, VF); UCSF Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital, San Francisco, CA (VF); Contra Costa Health Services, San Francisco, CA (RP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rajiv Pramanik
the Department of Family and Community Medicine at the University of Illinois at Chicago (HKH); Department of Family and Community Medicine, University of California San Francisco (MBP); Division of General Internal Medicine, Department of Medicine, University of California San Francisco (GG, LK, VF); Multiethnic Health Equity Research Center, University of California San Francisco (LK, VF); UCSF Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital, San Francisco, CA (VF); Contra Costa Health Services, San Francisco, CA (RP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael B. Potter
the Department of Family and Community Medicine at the University of Illinois at Chicago (HKH); Department of Family and Community Medicine, University of California San Francisco (MBP); Division of General Internal Medicine, Department of Medicine, University of California San Francisco (GG, LK, VF); Multiethnic Health Equity Research Center, University of California San Francisco (LK, VF); UCSF Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital, San Francisco, CA (VF); Contra Costa Health Services, San Francisco, CA (RP).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    1. Caulfield T,
    2. Fullerton SM,
    3. Ali-Khan SE,
    4. et al
    . Race and ancestry in biomedical research: exploring the challenges. Genome Med 2009;1:8.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Roberts DE
    . Is race-based medicine good for us?: African American approaches to race, biomedicine, and equality. J Law Med Ethics 2008;36:537–45.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Smart A,
    2. Weiner K
    . Racialised prescribing: enacting race/ethnicity in clinical practice guidelines and in accounts of clinical practice. Sociol Health Illn 2018;40:843–58.
    OpenUrl
  4. 4.↵
    1. Cerdeña JP,
    2. Plaisime MV,
    3. Tsai J
    . From race-based to race-conscious medicine: how anti-racist uprisings call us to act. The Lancet 2020;396:1125–8.
    OpenUrl
  5. 5.↵
    1. Westby AO,
    2. Ricco J
    . Race-based treatment decisions perpetuate structural racism. Am Fam Physician 2020. Available at: https://www.aafp.org/afp/2020/0801/p136.html. Accessed Nov 9, 2020.
  6. 6.↵
    1. Grubbs V
    . Precision in GFR Reporting. Clin J Am Soc Nephrol 2020;15:1201–2.:CJN.00690120.
    OpenUrlFREE Full Text
  7. 7.↵
    1. Goodman CW,
    2. Brett AS
    . Race and Pharmacogenomics—Personalized Medicine or Misguided Practice? JAMA 2021;325:625.
    OpenUrl
  8. 8.↵
    1. Braun L,
    2. Fausto-Sterling A,
    3. Fullwiley D,
    4. et al
    . Racial categories in medical practice: how useful are they? PLoS Med 2007;4:e271.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Corbie-Smith G,
    2. Henderson G,
    3. Blumenthal C,
    4. Dorrance J,
    5. Estroff S
    . Conceptualizing race in research. J Nat Med Assoc 2008;100:1235–43.
    OpenUrlPubMed
  10. 10.↵
    1. Reddick B
    . Fallacies and dangers of practicing race-based medicine. Am Fam Physician 2021;104:122–3. Aug 1.
    OpenUrl
  11. 11.↵
    1. Grossman DC,
    2. Curry SJ,
    3. Owens DK
    , US Preventive Services Task Force, et al. Screening for prostate cancer. JAMA 2018;319:1901–13.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Noor Chadha BL,
    2. Madelene KB
    . Rowland Toward the Abolition of Biological Race in Medicine. Institute OB; 2020. May 13, 2020.
  13. 13.↵
    1. Vyas DA,
    2. Eisenstein LG,
    3. Jones DS
    . Hidden in plain sight — reconsidering the use of race correction in clinical algorithms. N Engl J Med 2020;383:874–82.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Powe NR
    . Black kidney function matters: use or misuse of race? JAMA 2020;324:737–8.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Williams SK,
    2. Ravenell J,
    3. Seyedali S,
    4. Nayef H,
    5. Ogedegbe G
    . Hypertension treatment in blacks: discussion of the U.S. clinical practice guidelines. Prog Cardiovasc Dis 2016;59:282–8.
    OpenUrl
  16. 16.↵
    1. James PA,
    2. Oparil S,
    3. Carter BL,
    4. et al
    . 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507–20. Feb 5.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Whelton PK,
    2. Carey RM,
    3. Aronow WS,
    4. et al
    . 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Pr. Hypertension 2018;71:e13–e115.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Williams B,
    2. Mancia G,
    3. Spiering W
    , ESC Scientific Document Group, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018;39:3021–104.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Flack JM,
    2. Sica DA,
    3. Bakris G,
    4. et al
    . Management of high blood pressure in blacks. Hypertension 2010;56:780–800.
    OpenUrlCrossRef
  20. 20.↵
    1. Benjamin EJ,
    2. Muntner P,
    3. Alonso A
    , On behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, et al. Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association. Circulation 2019;139.
  21. 21.↵
    1. Musemwa N,
    2. Gadegbeku CA
    . Hypertension in African Americans. Curr Cardiol Rep 2017;19.
  22. 22.↵
    1. Laragh JH,
    2. Sealey JE
    . Relevance of the plasma renin hormonal control system that regulates blood pressure and sodium balance for correctly treating hypertension and for evaluating ALLHAT., Am J Hypertens 2003;16:407–15.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Wright JT,
    2. Bakris G,
    3. Greene T
    , African American Study of Kidney Disease and Hypertension Study Group, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease, results from the AASK Trial. JAMA 2002;288:2421–31.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Madhusoodanan J
    . Is a racially-biased algorithm delaying health care for one million Black people? Nature 2020;588:546–7.
    OpenUrl
  25. 25.↵
    1. Selby K,
    2. Michel M,
    3. Gildengorin G,
    4. et al
    . Disparities in hypertension control across and within three health systems participating in a data-sharing collaborative. J Am Board Fam Med 2018;31:897–904.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Benchimol EI,
    2. Smeeth L,
    3. Guttmann A
    , RECORD Working Committee, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLOS Med 2015;12:e1001885.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. FitzGerald C,
    2. Hurst S
    . Implicit bias in healthcare professionals: a systematic review. BMC Med Ethics. 2017;18:19 2017/03/01.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Schulman KA,
    2. Berlin JA,
    3. Harless W,
    4. et al
    . The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med 1999;340:618–26.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Ravenell J,
    2. Ogedegbe G
    . Unconscious bias and real-world hypertension outcomes: advancing disparities research. J Gen Intern Med 2014;29:973–5. Jul.
    OpenUrl
  30. 30.↵
    1. Nelson A
    . Unequal treatment: confronting racial and ethnic disparities in health care. J Natl Med Assoc 2002;94:666–8.
    OpenUrlPubMed
  31. 31.↵
    1. Adler NE,
    2. Glymour MM,
    3. Fielding J
    . Addressing social determinants of health and health inequalities. JAMA 2016;316:1641–2.
    OpenUrlPubMed
  32. 32.↵
    1. Chetty R,
    2. Stepner M,
    3. Abraham S,
    4. et al
    . The association between income and life expectancy in the United States, 2001-2014. JAMA 2016;315:1750–66.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. De Mendoza VB,
    2. Huang Y,
    3. Crusto CA,
    4. Sun YV,
    5. Taylor JY
    . Perceived racial discrimination and DNA methylation among African American women in the InterGEN Study. Biological Research For Nursing 2018;20:145–52.
    OpenUrl
  34. 34.↵
    1. Gruenewald TL,
    2. Karlamangla AS,
    3. Hu P,
    4. et al
    . History of socioeconomic disadvantage and allostatic load in later life. Soc Sci Med 2012;74:75–83.
    OpenUrlCrossRefPubMed
  35. 35.↵
    Chronic Kidney Disease Surveillance System—United States. website. Center for Disease Control and Prevention. Available at: http://www.cdc.gov/ckd. Accessed March 18, 2021.
  36. 36.↵
    1. Celious A,
    2. Oyserman D
    . Race from the inside: an emerging heterogeneous race model. J Social Isssues 2001;57:149–65.
    OpenUrl
  37. 37.↵
    1. McKinley LA,
    2. Smith JR,
    3. Marshall KP
    . The Myth of the Monolithic Minority: The Renewed Call for Effective Segmentation of African American Consumers. Springer International Publishing; 2015:92–9.
  38. 38.↵
    1. Klinger EV,
    2. Carlini SV,
    3. Gonzalez I,
    4. et al
    . Accuracy of race, ethnicity, and language preference in an electronic health record. J GEN INTERN MED 2015;30:719–23.
    OpenUrlPubMed
  39. 39.↵
    1. Galozy A,
    2. Nowaczyk S,
    3. Sant'Anna A,
    4. Ohlsson M,
    5. Lingman M
    . Pitfalls of medication adherence approximation through EHR and pharmacy records: definitions, data and computation. International Journal of Medical Informatics 2020;136:104092.
    OpenUrl
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Medicine: 35 (1)
The Journal of the American Board of Family Medicine
Vol. 35, Issue 1
January/February 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Differences in Hypertension Medication Prescribing for Black Americans and Their Association with Hypertension Outcomes
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Differences in Hypertension Medication Prescribing for Black Americans and Their Association with Hypertension Outcomes
Hunter K. Holt, Ginny Gildengorin, Leah Karliner, Valy Fontil, Rajiv Pramanik, Michael B. Potter
The Journal of the American Board of Family Medicine Jan 2022, 35 (1) 26-34; DOI: 10.3122/jabfm.2022.01.210276

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Differences in Hypertension Medication Prescribing for Black Americans and Their Association with Hypertension Outcomes
Hunter K. Holt, Ginny Gildengorin, Leah Karliner, Valy Fontil, Rajiv Pramanik, Michael B. Potter
The Journal of the American Board of Family Medicine Jan 2022, 35 (1) 26-34; DOI: 10.3122/jabfm.2022.01.210276
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Background
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • Notes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Increasing Primary Care Utilization of Medication-Assisted Treatment (MAT) for Opioid Use Disorder
  • Priorities for Artificial Intelligence Applications in Primary Care: A Canadian Deliberative Dialogue with Patients, Providers, and Health System Leaders
  • Associations Between High Pain Catastrophizing and Opioid-Related Awareness and Beliefs Among Patients in Primary Care
Show more Original Research

Similar Articles

Keywords

  • Health Equity
  • Hypertension
  • Precision Medicine
  • Prescriptions
  • Primary Health Care
  • Retrospective Studies

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2023 American Board of Family Medicine

Powered by HighWire